Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-15-000548
Filing Date
2015-05-15
Accepted
2015-05-15 11:59:23
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2015-03-31 aoxing.htm 10-Q 579995
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh311.htm EX-31.1 9130
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxingexh312.htm EX-31.2 9279
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh321.htm EX-32.1 5058
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxingexh322.htm EX-32.2 5131
  Complete submission text file 0001096906-15-000548.txt   3415682

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20150331.xml EX-101.INS 478993
7 XBRL SCHEMA DOCUMENT axn-20150331.xsd EX-101.SCH 31126
8 XBRL CALCULATION LINKBASE DOCUMENT axn-20150331_cal.xml EX-101.CAL 21664
9 XBRL DEFINITION LINKBASE DOCUMENT axn-20150331_def.xml EX-101.DEF 37554
10 XBRL LABELS LINKBASE DOCUMENT axn-20150331_lab.xml EX-101.LAB 146611
11 XBRL PRESENTATION LINKBASE DOCUMENT axn-20150331_pre.xml EX-101.PRE 132787
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 15866891
SIC: 2834 Pharmaceutical Preparations